12 Biggest Mid-Day Gainers For Friday

ContraVir Pharmaceuticals Inc CTRV shares climbed 30.9 percent to $1.78. ContraVir Pharmaceuticals shares have dropped 42.62 percent over the past 52 weeks, while the S&P 500 index has gained 6.94 percent in the same period.
First Bancshares Inc FBMS shares jumped 23 percent to $22.00. First Bancshares reported Q3 net income of $2.6 million on revenue of $13.2 million.
MGT Capital Investments Inc. MGT gained 19.7 peecent to $2.52. MGT Capital issued news on the commercial launch of its Sentinel. MGT Capital Investments shares have jumped 439.74 percent over the past 52 weeks, while the S&P 500 index has increased 6.94 percent in the same period.
Enzo Biochem, Inc. ENZ shares climbed 10.3 percent to $5.59. Enzo Biochem reported Q4 non-GAAP earnings of $0.04 per share on revenue of $26.6 million.
Skyline Corporation SKY shares gained 9.4 percent to $13.00. Skyline reported Q1 earnings of $0.09 per share, versus a year-ago loss of $0.10 per share.
Ballard Power Systems Inc. (USA) BLDP shares rose 9.3 percent to $2.40. Ballard Power Systems is expected to release Q3 operating results on October 26, 2016.
Advanced Micro Devices, Inc. AMD shares gained 6.8 percent to $6.93 following the announcement that the company has reached a deal with Alibaba Group Holding Ltd BABA to use AMD chips in its cloud service.
Sprint Corp S shares rose 4.4 percent to $7.07. Sprint is expected to release FQ2 earnings on October 25, 2016..
Louisiana-Pacific Corporation LPX shares gained 3.6 percent to $19.13. Louisiana-Pacific is expected to release Q3 financial results on October 31, 2016.
CIRCOR International, Inc. CIR shares rose 2.6 percent to $50.87. SunTrust upgraded CIRCOR from Reduce to Hold.
Zumiez Inc. ZUMZ gained 2.6 percent to $22.48. Piper Jaffray upgraded Zumiez from Neutral to Overweight.
Watsco Inc WSO shares rose 2.2 percent to $142.31. Longbow Research upgraded Watsco from Neutral to Buy.

Market News and Data brought to you by Benzinga APIs

Comments

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga